Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80
Organisation › Details

PinCell S.r.l.

PinCell is a biotechnology company targeting a novel pathological pathway to develop firstin-class anti-inflammatory therapies for the treatment of rare, severe skin diseases with high unmet medical need. Based in Milan, Italy, PinCell was founded in October 2008 as an academic spin-off of the University of Modena and Reggio Emilia by the world-class dermatology experts Prof. Carlo Pincelli and Dr. Alessandra Marconi. PinCell received seed funding from Sofinnova Partners. *

 

Period Start 2008-10-01 established (s-off
  Predecessor University of Modena
Products Industry dermatic
  Industry 2 drug development
Person Person Camboni, Gabriella (PinCell 202005– CEO + BiovelocITA 201511– CEO before EOS SpA Co-Founder + Novupharma Co-Founder)
     
Region Region Milano (Milan)
  Country Italy
  Street 8 Via Vincenzo Gioberti
  City 20123 Milano (MI)
  Tel +39-02-8399-1300
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for �About Section�: PinCell S.r.l.. (5/6/20). "Press Release: PinCell Appoints Veteran Biotech and Biopharma Executives to Management Team and Board of Directors. The Nominations Follow a Successful Seed Funding Led by Sofinnova Partners". Milan.
     
   
Record changed: 2020-05-20

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for PinCell S.r.l.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80




» top